Russell Investments Group’s Supernus Pharmaceuticals SUPN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.76M | Sell |
|
|||||
|
2025
Q1 | $2.46M | Sell |
|
|||||
|
2024
Q4 | $3.49M | Sell |
|
|||||
|
2024
Q3 | $3.42M | Buy |
|
|||||
|
2024
Q2 | $2.68M | Buy |
|
|||||
|
2024
Q1 | $3.34M | Buy |
|
|||||
|
2023
Q4 | $929K | Buy |
|
|||||
|
2023
Q3 | $824K | Sell |
|
|||||
|
2023
Q2 | $1.52M | Buy |
|
|||||
|
2023
Q1 | $1.83M | Buy |
|
|||||
|
2022
Q4 | $1.26M | Hold |
|
|||||
|
2022
Q3 | $1.2M | Buy |
|
|||||
|
2022
Q2 | $426K | Hold |
|
|||||
|
2022
Q1 | $476K | Sell |
|
|||||
|
2021
Q4 | $708K | Buy |
|
|||||
|
2021
Q3 | $393K | Sell |
|
|||||
|
2021
Q2 | $584K | Sell |
|
|||||
|
2021
Q1 | $1.98M | Sell |
|
|||||
|
2020
Q4 | $2.88M | Sell |
|
|||||
|
2020
Q3 | $3.78M | Sell |
|
|||||
|
2020
Q2 | $6.81M | Buy |
|
|||||
|
2020
Q1 | $2.23M | Buy |
|
|||||
|
2019
Q4 | $2.42M | Sell |
|
|||||
|
2019
Q3 | $5.02M | Sell |
|
|||||
|
2019
Q2 | $7.06M | Sell |
|
|||||
|
2019
Q1 | $8.19M | Sell |
|
|||||
|
2018
Q4 | $11.6M | Sell |
|
|||||
|
2018
Q3 | $19.5M | Sell |
|
|||||
|
2018
Q2 | $25.5M | Sell |
|
|||||
|
2018
Q1 | $43.3M | Buy |
|
|||||
|
2017
Q4 | $36.4M | Buy |
|
|||||
|
2017
Q3 | $33.5M | Sell |
|
|||||
|
2017
Q2 | $44M | Buy |
|
|||||
|
2017
Q1 | $27.4M | Buy |
|
|||||
|
2016
Q4 | $21.8M | Buy |
|